NOT-HL-17-548: NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-18-023 "Stimulating Access to Research in Residency (StARR) (R38)"

NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-18-023 "Stimulating Access to Research in Residency (StARR) (R38)"

Notice Number: NOT-HL-17-548

Key Dates
Release Date: September 28, 2017

Related Announcements
NOT-HL-17-359
NOT-HL-17-533
RFA-HL-18-023

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The intent of this Notice is to inform potential applicants that NHLBI has posted a set of responses to Frequently Asked Questions (FAQs) regarding RFA-HL-18-023 "Stimulating Access to Research in Residency (StARR) (R38)". The FAQs are available on the NHLBI website at the following link:

https://www.nhlbi.nih.gov/research/funding/faq-rfa-hl-18-023-stimulating-access-research-residency

Although not required for application, applicants are strongly encouraged to review the FAQs (which may be updated at any time without additional notice) prior to submitting their application.

Inquiries

Please direct all inquiries to:

Neil Raj Aggarwal, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-7820
Email: [email protected]

Mark Damico, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5630
Email: [email protected]

Shawn Gaillard, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3857
Email: [email protected]